US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invion Ltd

0.0369

0.0000

Volume:- -

Turnover:- -

Market Cap:3.13M

PE:-0.57

High:0.0369

Open:0.0369

Low:0.0369

Close:0.0369

52wk High:0.0369

52wk Low:0.0369

Shares:84.88M

Float Shares:56.20M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0652

EPS(LYR):-0.0584

ROE:-77.64%

ROA:-44.16%

PB:0.54

PE(LYR):-0.63

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Invion Ltd

Exchange:

PINK LIMITED

Establishment Date:

2000

Employees:

4

Office Location:

385 Bourke Street,Suite 2, Level 11,Melbourne,Victoria,Australia

Website:

http://www.inviongroup.com/

Zip Code:

3000

Phone:

Fax:

- -

Introduction:

Invion Limited, a clinical-stage life-sciences company, researches and develops photodynamic therapy for the treatment of various cancers in Australia. The company is developing IVX-PDT, a photosensitizer agent to treat skin cancers, as well as solid cancers, including lung, prostrate, ovarian, and mesothelioma cancers. It has a research and development agreement with Hudson Institute of Medical Research to collaborate on a range of research and development projects for the Photosoft technology for the treatment of a range of cancers; and research agreement with Peter MacCallum Cancer Centre to undertake pre-clinical and in-vitro studies on Invion's IVX-PDT Photodynamic therapy for ano-genital cancers, including penile and anal cancer. The company was incorporated in 2000 and is headquartered in Melbourne, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/IVIXF/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IVIXF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IVIXF\",,,,,undefined,":{"symbol":"IVIXF","market":"US","secType":"STK","nameCN":"Invion Ltd","latestPrice":0.0369,"timestamp":1770752040000,"preClose":0.0369,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":56201428,"shares":84875801,"eps":-0.065182,"marketStatus":"Trading","change":0,"latestTime":"02-10 14:34:00 EST Delay","open":0.0369,"high":0.0369,"low":0.0369,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.065182,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1770757200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"PINK LIMITED","adjPreClose":0.0369,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IVIXF\",,,,,undefined,":{"symbol":"IVIXF","floatShares":56201428,"roa":"-44.16%","roe":"-77.64%","lyrEps":-0.058446,"shares":84875801,"dividePrice":0,"high":0.0369,"amplitude":0,"preClose":0.0369,"low":0.0369,"week52Low":0.0369,"pbRate":"0.54","psRate":"1467.63","week52High":0.0369,"institutionHeld":0,"latestPrice":0.0369,"eps":-0.065182,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.065182,"open":0.0369,"prevYearClose":0.0369,"prevWeekClose":0.0369,"prevMonthClose":0.0369,"prevQuarterClose":0.0369,"fiveDayClose":0.0369,"twentyDayClose":0.0369,"sixtyDayClose":0.0369},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IVIXF\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-11-20","symbol":"IVIXF","defaultRemindTime":1732113000000,"type":"split","dateTimestamp":1732078800000,"forFactor":100,"toFactor":1,"ratio":100},{"market":"US","date":"2022-10-17","symbol":"IVIXF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1665979200000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2022-08-17","symbol":"IVIXF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1660708800000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IVIXF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IVIXF\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":28625535,"yearFounded":2000,"employeeNum":4,"address":"385 Bourke Street,Suite 2, Level 11,Melbourne,Victoria,Australia","zipCode":"3000","officePhone":"61 3 9692 7222"},"stockCompanyDetail":{"websiteUrl":"http://www.inviongroup.com/","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":-0.6865},{"period":"ytd","weight":0}],"description":"Invion Limited, a clinical-stage life-sciences company, researches and develops photodynamic therapy for the treatment of various cancers in Australia. The company is developing IVX-PDT, a photosensitizer agent to treat skin cancers, as well as solid cancers, including lung, prostrate, ovarian, and mesothelioma cancers. It has a research and development agreement with Hudson Institute of Medical Research to collaborate on a range of research and development projects for the Photosoft technology for the treatment of a range of cancers; and research agreement with Peter MacCallum Cancer Centre to undertake pre-clinical and in-vitro studies on Invion's IVX-PDT Photodynamic therapy for ano-genital cancers, including penile and anal cancer. The company was incorporated in 2000 and is headquartered in Melbourne, Australia.","exchange":"PINK LIMITED","name":"Invion Ltd","nameEN":"Invion Ltd"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"IVIXF\",market:\"US\",,,undefined,":null}}